Liraglutide

Liraglutide is a GLP-1 receptor agonist approved for the treatment of type 2 diabetes and obesity. It works by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying, leading to better blood sugar control and weight loss. Its role in weight management makes it a popular choice for patients looking to control both diabetes and obesity.